ArticleJournal of health economics and outcomes research2026

A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata.

Ashley S Cha-Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.